The changing landscape of crack cocaine use and HIV infection.
Celentano
David
D
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. dcelenta@jhsph.edu
Sherman
Susan G
SG
D001955:British Columbia / Q000453:epidemiology; D019970:Cocaine-Related Disorders / Q000175:diagnosis / Q000453:epidemiology*; D015897:Comorbidity; D016578:Crack Cocaine / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000453:epidemiology*; D006679:HIV Seropositivity / Q000175:diagnosis / Q000453:epidemiology*; D006801:Humans; D008297:Male; D015995:Prevalence; D018570:Risk Assessment; D012309:Risk-Taking; D017678:Sex Distribution; D012725:Sexual Behavior; D014505:Urban Population
D016578:Crack Cocaine